BioTime’s Renevia® Achieves Primary Endpoint in European Pivotal Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/24/2026

1. NVDA
2. JMKE
3. SPY
4. BABA
5. REF
6. XPEV
7. USO
8. TSLA
9. REAX
10. BA

Go back to BioTime’s Renevia® Achieves Primary Endpoint in European Pivotal Trial
Hastings Entertainment, Inc. (NYSE: AST) Delayed: 0.95 --0 (-0%)
Previous Close $0.95    52 Week High $5.75 
Open $19.21    52 Week Low $2.30 
Day High $0.95    P/E 1.02 
Day Low $0.95    EPS $0.93 
Volume 1       

BIOTIME, Inc. (NYSE: BTX) Delayed: 8.80 -0.21 (2.33%)
Previous Close $9.01    52 Week High $4.51 
Open $8.95    52 Week Low $2.02 
Day High $8.99    P/E N/A 
Day Low $8.78    EPS $-0.58 
Volume 450,631       

BIOTIME, Inc. (NYSE: BTX) Delayed: 8.80 -0.21 (2.33%)
Previous Close $9.01    52 Week High $4.51 
Open $8.95    52 Week Low $2.02 
Day High $8.99    P/E N/A 
Day Low $8.78    EPS $-0.58 
Volume 450,631       

BIOTIME, Inc. (NYSE: BTX) Delayed: 8.80 -0.21 (2.33%)
Previous Close $9.01    52 Week High $4.51 
Open $8.95    52 Week Low $2.02 
Day High $8.99    P/E N/A 
Day Low $8.78    EPS $-0.58 
Volume 450,631